Elliot Gruen
Psychiatry · Lewiston, MENPI 1295760106
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 379 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,372 and has fallen 52.8% since, to $1,120 in 2022. Among psychiatry clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 379 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Vanda Pharmaceuticals Inc.$1K
- Neurocrine Biosciences, Inc.$916
- Sunovion Pharmaceuticals Inc.$899
- Takeda Pharmaceuticals U.S.A., Inc.$844
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$808
- plus $2K from 10 others
What the payments were for
- Food & beverage$7,472100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 52 | $1,085 |
| Vanda Pharmaceuticals Inc. | 40 | $1,068 |
| Neurocrine Biosciences, Inc. | 37 | $916 |
| Sunovion Pharmaceuticals Inc. | 61 | $899 |
| Takeda Pharmaceuticals U.S.A., Inc. | 40 | $844 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 46 | $808 |
| Johnson & Johnson | 19 | $374 |
| Lundbeck LLC | 18 | $359 |
| AbbVie(2 entities) | 19 | $320 |
| Eisai Inc. | 20 | $319 |
| Shire North American Group Inc | 13 | $203 |
| Alkermes, Inc. | 7 | $141 |
| Neos Therapeutics, LP | 2 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $42 |
| Avanir Pharmaceuticals, Inc. | 2 | $35 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
How this compares
$7,472 in reported general payments places this provider in the 95th percentile of 167 psychiatry providers in Maine.
Other psychiatry in Lewiston
- Thaddeus ShattuckLewiston$968
- Brigitte HristeaLewiston$779
- Colin PopeLewiston$263
- Ryan SmithEastport$92K
- Edward BilottiSouth Portland$88K
- Ira ScottBangor$27K
- Charmaine PatelBangor$17K
- Glenn CurrierPortland$8K
- David JonesArundel$5K
- Christine WhitePrinceton$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.